ExCellThera’s Zemcelpro scores big in Germany, paving way for early hospital access
The therapy, also known as UM171 Cell Therapy, recently received conditional marketing authorization from the European Commission
The therapy, also known as UM171 Cell Therapy, recently received conditional marketing authorization from the European Commission
The new service delivers end-to-end support, managing every stage of an epigenomics project
The new functionality complements Parse’s existing Evercode immune products
The product delivers 100 percent of the Recommended Dietary Allowance (RDA) of three essential nutrients—Biotin, Vitamin C and Zinc
The randomized, double-blind, placebo-controlled Phase 2b VITAL trial enrolled 91 patients with newly diagnosed Stage IIIb–IV epithelial ovarian cancer
The partnership aims to fuse Avantium’s breakthrough materials with Packamama’s expertise in low-emission, innovative wine bottles
Blood tests measuring biomarkers such as p-tau217 are emerging as accurate, accessible alternatives
The SNS records neural activity from 60 channels across four brain regions—far exceeding current commercial devices
He noted the enduring relevance of Siddha medicine as “a comprehensive, preventive and sustainable healthcare system in the contemporary world
INOVIO remains confident in the therapy’s benefits and intends to meet with the FDA to discuss maintaining eligibility under this pathway
Subscribe To Our Newsletter & Stay Updated